학술논문
P1324: A RISK-BASED STRATEGY FOR THE USE OF LETERMOVIR IN CMV-POSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
Document Type
article
Author
Source
HemaSphere, Vol 6, Pp 1209-1210 (2022)
Subject
Language
English
ISSN
2572-9241